T1	Limited_variation	21 41	genotypes of CYP2C19
T2	Limited_variation	46 61	MDRI C3435T are
T3	Pharmacokinetic_phenotype	115 172	pharmacokinetic variability of lansoprazole ( LSZ ) , the
T4	Limited_variation	237 252	CYP2C19 and MDR
T5	Limited_variation	254 281	C3435T polymorphisms on the
T6	Pharmacokinetic_phenotype	282 324	pharmacokinetics difference of LSZ and its
T7	Pharmacodynamic_phenotype	347 408	 lansoprazole ( HLSZ ) and lansoprazole sulphone ( LSZS ) fol
R1	influences	Arg1:T1	Arg2:T2
R2	influences	Arg1:T1	Arg2:T3
R3	influences	Arg1:T1	Arg2:T4
R4	influences	Arg1:T1	Arg2:T5
R5	influences	Arg1:T1	Arg2:T6
R6	influences	Arg1:T1	Arg2:T7
R7	influences	Arg1:T2	Arg2:T1
R8	influences	Arg1:T2	Arg2:T3
R9	influences	Arg1:T2	Arg2:T4
R10	influences	Arg1:T2	Arg2:T5
R11	influences	Arg1:T2	Arg2:T6
R12	influences	Arg1:T2	Arg2:T7
R13	isAssociatedWith	Arg1:T3	Arg2:T1
R14	isAssociatedWith	Arg1:T3	Arg2:T2
R15	isAssociatedWith	Arg1:T3	Arg2:T4
R16	influences	Arg1:T3	Arg2:T6
R17	influences	Arg1:T3	Arg2:T7
R18	influences	Arg1:T4	Arg2:T1
R19	influences	Arg1:T4	Arg2:T2
R20	influences	Arg1:T4	Arg2:T3
R21	influences	Arg1:T4	Arg2:T5
R22	influences	Arg1:T4	Arg2:T6
R23	influences	Arg1:T4	Arg2:T7
R24	influences	Arg1:T5	Arg2:T1
R25	influences	Arg1:T5	Arg2:T2
R26	influences	Arg1:T5	Arg2:T3
R27	influences	Arg1:T5	Arg2:T4
R28	influences	Arg1:T5	Arg2:T6
R29	influences	Arg1:T5	Arg2:T7
R30	isAssociatedWith	Arg1:T6	Arg2:T1
R31	isAssociatedWith	Arg1:T6	Arg2:T2
R32	influences	Arg1:T6	Arg2:T3
R33	isAssociatedWith	Arg1:T6	Arg2:T4
R34	isAssociatedWith	Arg1:T6	Arg2:T5
R35	influences	Arg1:T6	Arg2:T7
R36	isAssociatedWith	Arg1:T7	Arg2:T1
R37	isAssociatedWith	Arg1:T7	Arg2:T2
R38	isAssociatedWith	Arg1:T7	Arg2:T3
R39	isAssociatedWith	Arg1:T7	Arg2:T4
R40	isAssociatedWith	Arg1:T7	Arg2:T5
R41	influences	Arg1:T7	Arg2:T6
